Technical Analysis for PACB - Pacific Biosciences of California, Inc.

Grade Last Price % Change Price Change
grade C 7.34 0.82% 0.06
PACB closed up 0.82 percent on Friday, January 18, 2019, on 44 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Down Up
See historical PACB trend table...

Date Alert Name Type % Chg
Dec 10 1,2,3 Pullback Bullish Bullish Swing Setup -2.39%
Dec 10 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -2.39%
Dec 10 Bollinger Band Squeeze Range Contraction -2.39%
Dec 10 Narrow Range Bar Range Contraction -2.39%
Dec 7 Fell Below 20 DMA Bearish -2.52%
Dec 7 1,2,3 Pullback Bullish Bullish Swing Setup -2.52%
Dec 7 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -2.52%
Dec 7 Bollinger Band Squeeze Range Contraction -2.52%
Dec 6 20 DMA Support Bullish -4.68%
Dec 6 Hammer Candlestick Bullish -4.68%

Older signals for PACB ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Pacific Biosciences of California, Inc. develops, manufactures, and markets an integrated platform for genetic analysis. The company engages in developing a single molecule, real-time, (SMRT) technology for the detection of biological processes. Its SMRT technology enables to study the synthesis, composition, structure, and regulation of DNA, as well as to record individual biochemical events as they occur. It primarily focuses on the deoxyribonucleic acid sequencing market. The company's product includes the PacBio RS high resolution genetic analyzer, an instrument that conducts, monitors, and analyzes single molecule biochemical reactions in real time. Its PacBio RS high resolution genetic analyzer consists of an instrument platform that uses its proprietary consumables, such as SMRT Cells and reagent kits to prepare and sequence DNA samples. The company's customers include genome centers, genomics service providers, and agricultural companies, as well as clinical, government, and academic institutions. Pacific Biosciences of California, Inc. markets its products through a direct sales force in North America and Europe, as well as through distributors in Asia. The company was formerly known as Nanofluidics, Inc. Pacific Biosciences of California, Inc. was founded in 2000 and is headquartered in Menlo Park, California.
Is PACB a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Jan 17 Report: Exploring Fundamental Drivers Behind SkyWest, Pacific Biosciences of California, Lennar, Regeneron Pharmaceuticals, MGM Growth Properties, and Cincinnati Bell — New Horizons, Emerging Trends, and Upcoming Developments
Jan 4 LMNX or PACB: Which is a Better MedTech Investment Pick?
Dec 31 Bragar Eagel & Squire, P.C. Reminds Investors that it is Investigating the Boards of Directors of Red Hat, LSC Communications, Intersections, and Pacific Biosciences on Behalf of Stockholders and Encourages Investors to Contact the Firm
Dec 18 INVESTOR ALERT: Monteverde & Associates PC Is Investigating The Acquisition Of Pacific Biosciences of California, Inc. Scheduled For A Shareholder Vote On January 24, 2019 – PACB
Dec 13 Wolf Haldenstein Adler Freeman & Herz LLP announces that it has filed a class action complaint in the United States District Court for the Northern District of California on behalf of holders of Pacific Biosciences of California, Inc.
Dec 10 Bragar Eagel & Squire, P.C. is Investigating the Board of Directors of Pacific Biosciences of California, Inc. (PACB) on Behalf of Stockholders and Encourages PACB Investors to Contact the Firm
Dec 7 PACIFIC BIOSCIENCES OF CALIFORNIA, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout
Dec 7 SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of Pacific Biosciences of California, Inc. - PACB
Dec 6 Here's Why You Should Hold Pacific Biosciences (PACB) Now
Nov 28 Pacific Biosciences of California Has Seen Solid Growth in 2018
See more PACB news...
Indicators
Indicator Value
52 Week High 7.84
52 Week Low 2.02
Average Volume 2,757,895
200-Day Moving Average 4.6746
50-Day Moving Average 7.4784
20-Day Moving Average 7.316
10-Day Moving Average 7.258
Average True Range 0.1294
ADX 24.88
+DI 17.773
-DI 24.3172
Chandelier Exit (Long, 3 ATRs ) 7.1218
Chandelier Exit (Short, 3 ATRs ) 7.4382
Upper Bollinger Band 7.484
Lower Bollinger Band 7.148
Percent B (%b) 0.57
BandWidth 4.592674
MACD Line -0.0087
MACD Signal Line 0.0103
MACD Histogram -0.0189
Fundamentals Value
Market Cap 848.44 Million
Num Shares 116 Million
EPS -0.92
Price-to-Earnings (P/E) Ratio -7.98
Price-to-Sales 5.01
Price-to-Book 4.14
PEG Ratio -0.16
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 7.52
Resistance 3 (R3) 7.50 7.43 7.49
Resistance 2 (R2) 7.43 7.38 7.44 7.48
Resistance 1 (R1) 7.38 7.35 7.41 7.40 7.47
Pivot Point 7.31 7.31 7.32 7.32 7.31
Support 1 (S1) 7.26 7.26 7.29 7.28 7.21
Support 2 (S2) 7.19 7.23 7.20 7.20
Support 3 (S3) 7.14 7.19 7.19
Support 4 (S4) 7.16